✦ LIBER ✦

A novel modification of a flow cytometric assay of phosphorylated STAT1 in whole blood lymphocytes for rapid detection of interferon-α signal in vivo

✍ Scribed by Shiro Tochizawa; Yasukazu Ohmoto; Toyoki Mori

Book ID: 113717215
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 372 KB
Volume: 313
Category: Article
ISSN: 0022-1759
DOI: 10.1016/j.jim.2006.03.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Novel Modification of a Flow Cytometri

A Novel Modification of a Flow Cytometric Assay of Phosphorylated STAT1 in Whole Blood Monocytes for Immunomonitoring of Patients on IFNα Regimen

✍ J. Vakkila; U. Nieminen; S. Siitonen; U. Turunen; L. Halme; H. Nuutinen; H. Must 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

A rapid flow cytometric method for the d

A rapid flow cytometric method for the detection of intracellular cyclooxygenases in human whole blood monocytes and a COX-2 inducible human cell line

✍ Joyce J Ruitenberg; Cory A Waters 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 259 KB

Development and evaluation of a flow-cyt

Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus

✍ A. Svahn; A. Linde; R. Thorstensson; K. Karlén; L. Andersson; H. Gaines 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 230 KB

Ethylenediaminetetraacetic acid plus cit

Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): A novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood

✍ Macey, Marion ;McCarthy, Desmond ;Azam, Urooj ;Milne, Timothy ;Golledge, Peter ; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

## Abstract Ethylenediaminetetraacetic acid (EDTA) is the anticoagulant recommended for full blood counts, citrate is recommended for coagulation and platelet studies, and citrate‐theophylline‐adenosine‐dipyridamole (CTAD) inhibits platelet activation. Because the combination of EDTA and CTAD (E/C)